AI drives boost in healthcare venture capital: Report

Full Article

Venture capital investment in healthcare surged to $23 billion in 2024, up from $20 billion in 2023, largely due to the rapid adoption of AI technologies. A report from Silicon Valley Bank highlighted that AI accounted for 30% of all healthcare investments, particularly transforming the biopharma sector. Notably, biopharma AI investments alone exceeded $5 billion, marking a 300% increase from the previous year.

Seed-stage investments represented 40% of all deals, with a significant rise in AI utilization among these companies, increasing from 25% to 35%. Established healthtech firms continued to attract substantial funding, while newer startups faced pressure to show quick results. Innovations in hospital-focused technologies, especially in imaging and monitoring, gained renewed interest, overshadowing the declining enthusiasm for wearables and home care devices.

• Healthcare venture capital reached $23 billion in 2024, driven by AI adoption.

• Biopharma AI investments surged to over $5 billion, a 300% increase.

Key AI Terms Mentioned in this Article

Venture Capital

Venture capital refers to funding provided to startups and small businesses with high growth potential, particularly in the healthcare sector.

Seed-Stage Investments

Seed-stage investments are early funding rounds for startups, crucial for developing initial products and market strategies.

Biopharma

Biopharma involves the use of biological processes for drug development, significantly impacted by AI technologies in investment and innovation.

Companies Mentioned in this Article

Silicon Valley Bank

Silicon Valley Bank specializes in providing financial services to technology and life sciences companies, playing a key role in funding AI-driven healthcare innovations.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 7month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 7month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 7month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 7month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics